Alnylam Pharmaceuticals ALNY Revenue Breakdown

NASDAQ ALNY
$147.82 -1.58 (-1.06%)
At close: Nov 19, 2026 · 4:00 PM EST
Quarterly revenue breakdowns for Alnylam Pharmaceuticals, quarters ended Dec 2021 to Sep 2026, as reported in its filings.
Quarterly history

Alnylam Pharmaceuticals Quarterly Revenue by Product & Service

Quarters Dec 2021–Sep 2026
Lines 3
Sep 2026 Total $1.46B

Net Product Revenues was Alnylam Pharmaceuticals’s largest product and service line in the Sep 2026 quarter, bringing in $1.29B of $1.46B (89%).

Alnylam Pharmaceuticals revenue by product and service, quarters ended Dec 2021 to Sep 2026
Product and Service Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Net Product Revenues $994.72M $1.04B $1.17B $1.29B
Net Revenues From Collaborations $40.94M $82.08M $47.17M $71.48M
Royalty Revenue $61.37M $48.97M $71.67M $94.66M
Total $1.10B $1.17B $1.29B $1.46B
Totals include 2 discontinued lines from earlier reporting.

Alnylam Pharmaceuticals Revenue Breakdown API

Pull Alnylam Pharmaceuticals's revenue breakdown - every line it reports, for every period - into your own models, spreadsheets and apps with the Business Quant Segments API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/segments?series=Revenue&ticker=ALNY&dimension=Quarter&api_key=YOUR_API_KEY